Novo Nordisk Has A Plan To Get Wegovy Launch Back On The Rails

 
• By Jessica Merrill

The company is targeting revenues of DKK25bn ($3.66bn) from Wegovy for obesity in 2025, with plans to amp up the US launch this year following an initial supply disruption.

railroad tracks
Novo Nordisk is ready to get Wegovy back on track • Source: Alamy

More from Alimentary/Metabolic

More from Therapy Areas